ADVFN US – Market Content Editor
-
Envoy Medical shares skyrocket after FDA clears final stage of pivotal Acclaim® cochlear implant trial
Envoy Medical Inc. (NASDAQ:COCH) saw its shares soar 150% in premarket trading on Tuesday after the company announced that the U.S. Food and Drug Administration (FDA) had granted approval to expand its pivotal clinical trial for the fully implanted Acclaim® cochlear implant, allowing the study to progress to its final stage. The regulatory approval eliminates…
-
IREN shares climb after securing new multi-year AI cloud contracts
IREN Limited (NASDAQ:IREN) stock jumped 7.1% in premarket trading on Tuesday after the company announced a series of new multi-year cloud service agreements with major artificial intelligence (AI) clients for NVIDIA Blackwell GPU deployments. The AI infrastructure company said it has now signed customer contracts covering 11,000 of the 23,000 GPUs currently in operation or…
-
AST SpaceMobile shares decline after announcing $800 million at-the-market offering
Shares of AST SpaceMobile Inc. (NASDAQ:ASTS) dropped 7% on Tuesday morning after the satellite communications company announced plans to raise up to $800 million through an at-the-market (ATM) stock offering. In a recent regulatory filing, AST SpaceMobile said it had entered into an equity distribution agreement with ten major investment banks that will act as…
-
Dow Jones, S&P, Nasdaq, Futures, Wall Street Set for Flat Open as Investors Monitor U.S. Budget Stalemate and Fed Comments
U.S. stock futures pointed to a steady start on Tuesday, with investors showing little conviction after Monday’s rally pushed major indexes to new highs. Caution prevailed as traders kept a close eye on Washington’s latest budget gridlock, where lawmakers once again failed to reach a deal on a short-term funding bill. The ongoing government shutdown,…
-
Ford Shares Slip After Fire at Key Aluminum Supplier Threatens F-150 Production
Ford Motor (NYSE:F) shares fell 1.6% in early trading on Tuesday after a Wall Street Journal report revealed that a major fire at a key aluminum supplier’s facility could disrupt the automaker’s production for several months. The blaze destroyed a large portion of Novelis’s Oswego, New York plant, which supplies about 40% of the aluminum…
-
Rekor Systems Shares Jump 23% After Landing $50 Million Georgia DOT Contract
Rekor Systems (NASDAQ:REKR) shares surged 23% on Tuesday after the company announced it had secured its largest statewide contract to date with the Georgia Department of Transportation (GDOT) — a deal valued at a minimum of $50 million over its full term. The multi-year agreement, which may be extended up to seven years at GDOT’s…
-
Zeta Network Group Shares Skyrocket Over 250% Following Strategic Bitcoin Finance Partnership
Zeta Network Group (NASDAQ:ZNB) shares soared more than 250% on Tuesday after the company announced a strategic partnership with SOLV Foundation aimed at accelerating its Bitcoin-focused financial initiatives. Under the agreement, Zeta Network Group will leverage SOLV’s decentralized finance platform, which currently holds $2.5 billion in total value locked (TVL), to enhance the efficiency and…
-
James Hardie Shares Jump 10% After Strong Q2 Results Beat Analyst Forecasts
James Hardie Industries plc (NYSE:JHX) shares surged 10% on Tuesday after the building materials manufacturer posted preliminary second-quarter results that came in well above Wall Street expectations, thanks to resilient performance in its Siding & Trim division. The company said it expects net sales between $1.29 billion and $1.30 billion for the quarter — far…
-
Jade Biosciences Shares Jump 20% After Revealing Promising Autoimmune Therapy and $135 Million Funding Round
Jade Biosciences (NASDAQ:JBIO) shares surged 20% on Tuesday after the clinical-stage biotech company unveiled JADE201, a new potentially best-in-class therapy for autoimmune diseases, alongside news of a $135 million private investment in public equity (PIPE) financing round. JADE201 is an investigational half-life extended, afucosylated monoclonal antibody designed to target the B-cell activating factor receptor (BAFF-R).…
-
Lexeo Therapeutics Shares Surge 25% on FDA Accelerated Approval Pathway Progress
Lexeo Therapeutics (NASDAQ:LXEO) shares skyrocketed 25% on Tuesday after the clinical-stage genetic medicine company announced significant progress in its discussions with the U.S. Food and Drug Administration (FDA) regarding an accelerated approval pathway for LX2006, its investigational treatment for Friedreich ataxia cardiomyopathy. According to Lexeo, the FDA is open to allowing pooled data from the…